Citadel Advisors’s Diebold Nixdorf DBD Stock Holding History
Bought
Maintained
Sold
Other funds holding DBD
Citadel Advisors's DBD Position: Q3 2026 in Review
Citadel Advisors increased its Diebold Nixdorf (DBD) stake by 2,716% in Q3 2026, buying an estimated $5.42M and bringing the position to 76,520 shares worth $4.68M. The position accounts for ﹤0.01% of the portfolio, ranked #4964.
Citadel Advisors first reported a position in DBD in Q3 2023 and has held it in 11 quarters since. The position peaked at $8.53M in Q1 2026. 215 funds tracked by Wall St. Rank hold DBD as of Q3 2026.
- Citadel Advisors held 76,520 shares of Diebold Nixdorf worth $4.68M as of Q3 2026.
- Citadel Advisors bought 73,803 Diebold Nixdorf shares in Q3 2026, an estimated $5.42M.
- Diebold Nixdorf made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #4964 holding.
- Citadel Advisors first reported a position in Diebold Nixdorf in Q3 2023 and has held it in 11 quarters since.
- Citadel Advisors's Diebold Nixdorf position peaked at $8.53M in Q1 2026.
- 215 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.